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doi:10.1016/j.ejvs.2009.05.024Abstract Objectives: To assess self-management of chronic venous disorders (CVDs) in
a selected Italian population and the pattern of prescription by selected Italian phlebologists.
Design: Cross-sectional study carried out between 2003 and 2005.
Materials: Non-random, transverse sample of men and women recruited by advertising.
Methods: Assessment of therapeutic habits of respondents, treatment advice given by phlebol-
ogists related to socio-demographic variables and severity of the disease. Multivariate odds
ratios for sex, age, class, region, family history and severity of the disease.
Results: Women undergo CVD therapy more than men (odds ratio (OR): 2.37 for medical
treatment; 1.29 for surgical treatment and 5.72 for sclerotherapy). Young people prefer drug
treatment to compression stockings. Drug therapy for CVD is 1.5 times more likely in southern
Italian respondents, as is compression stockings (OR: 1.91). Surgical therapy is more frequent
in Northern Italy (OR for Central Italy: 0.79; Southern Italy and Islands: 0.76). Family history of
CVD leads people to early treatment of symptoms.
Conclusions: This study provides insight into self-medication of CVD in Italy and the prescribing
patterns of Italian phlebologists in the treatment of CVD. It shows that the population inter-
viewed is able to practise responsible self-medication of their CVD problems.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.ific Institute Hospital San
Via Olgettina, 20132 Milan,
02 2643 7148.
r.it (E.M. Marone).
ty for Vascular Surgery. PublisheVenous chronic disorders (CVDs) are a multifactorial
syndrome with a large social and economic impact.1,2 While
CVD cannot be cured, its progression can at least be slowed
down or, at best, be halted, provided an early diagnosis is
made. Therefore, timely education of the population on
the impact of CVD is important. In 2003, we started and by Elsevier Ltd. All rights reserved.
512 E.M. Marone et al.epidemiological survey linked to a nationwide CVD aware-
ness and prevention programme in Italy intended to inform
the population of the existence of problems linked to CVD
arising at a young age and to provide advice on how to
prevent and treat them. This programme has been
continued in 2004 and 2005, recruiting more than 35 000
participants in all. During the survey, a large quantity of
data has been collected and several aspects of this research
regarding demographic factors, clinical signs and quality-
of-life issues linked to CVD have already been published
elsewhere.3e6
During the programme, we collected data on CVD ther-
apies used by the respondents as well as those suggested by
the phlebologists during the medical visits. We have ana-
lysed the therapeutic habits of the subjects who joined the
survey as well as the treatment recommendations given by
the phlebologists during the visits and related them to
socio-demographic variables and the degree of severity of
the disease of the respondents.
Materials and Methods
Participants
This survey has been carried out as a cross-sectional study
between 2003 and 2005 during a nationwide awareness and
prevention programme promoted by the San Raffaele
Hospital (Milan, Italy) and the Italian Society of Vascular
and Endovascular Surgery. Fifty-three selected vascular
surgery units, distributed all over Italy and equipped to
perform specialised phlebological visits participated in the
programme. We studied a non-random, transverse sample
of women and men recruited by newspaper, radio and
television advertising and by flyers distributed in
pharmacies.
Participants had to be older than 18 years and registered
at a dedicated call centre or on the Internet for a medical
visit by a qualified vascular surgeon with specific training in
phlebology. No other specific inclusion or exclusion criteria
were set. The advertising text called for people who would
like to have a thorough physical examination of their legs
with regard to blood circulation. This survey did not require
any ethical committee’s approval in Italy, this being no
interventional study. To participate, however, subjects had
to provide their informed consent and agree to have their
medical and demographic data evaluated and published for
scientific purposes after anonymisation. Subsequently, they
underwent a medical visit that included a thorough inves-
tigation of their lower limbs to diagnose the presence of
CVD signs and symptoms as well as a colour-coded duplex
ultrasonography.
Data collection
Demographic (age, sex, pregnancies in female and body
mass index) and lifestyle data (physical activity and
smoking habit) as well as (for women) contraceptive use
were collected at the study visit. We restricted family
history of varicose veins to first-degree relatives only. This
information was elicited directly from the subjects and no
direct medical examination of the family members tookplace. Data on history of deep thrombotic events, leg
arterial disease, haemorrhoids and varicocoele were
collected as well. Visible signs of venous disease such as
telangiectases, varicose veins, oedema, trophic changes
and ulcers were assessed by a trained vascular surgeon.
Clinical signs were classified according to the clinical,
etiologic, anatomic and pathophysiological (CEAP) clinical
classification.7
Subjects were also asked to report their subjective
perception of lower limb symptoms of CVD such as heavy/
tired legs, pain and swollen leg. The respondents provided
information about ongoing or completed, self-chosen or
prescribed CVD therapies, divided into four main categories
as follows: (1) drug therapy, includes the use of either
synthetic drugs (heparins, anticoagulants, diuretics, vaso-
dilators and anti-oedema drugs) or herbal remedies (bio-
flavonoids: diosmin, rutosides, proanthocyanidines,
anthocyanidines and triterpenes: mainly aescin); (2)
compression stocking; (3) sclerotherapy; and 4) surgical
therapy. After the visit, the physicians used a case report
form to describe the type of therapy they had recom-
mended to the volunteer. No justification of the recom-
mendation had to be provided and each unit was allowed to
use their preferred pattern of prescription.
Statistical analysis
Information from questionnaires was entered into Microsoft
Excel. Data were then transferred into SAS (Statistical
Analysis System; SAS Institute, Inc., Cary, NC, USA), version
8.02, for statistical analysis.
Descriptive statistics were computed for the four types
of therapy (drug therapy, compression stockings, scle-
rotherapy and surgical therapy) in relation to selected
demographic data (sex and age), family history, geographic
province of the respondent and severity of the disease
(CEAP classification). Univariate odds ratios (ORs) for each
type of therapy were computed for the variables sex, age,
class, region, family history and severity of disease. Multi-
variate ORs were computed for the same variables. The
significance level was set for all tests to aZ 0.05 (two-
tailed). Missing values were not replaced.
While studying the prevalence of CVD in the population
examined, cases were attributed to a class based on the
most severe degree of venous disease observed for either
limb examined.
Results
In general, between 2003 and 2005, 31 659 subjects
provided evaluable data. In 2003, we collected data from
4869 (15.4%) subjects, 16 251 (51.3%) in 2004 and 10 539
(33.3%) in 2005. Demographic data are presented in
Table 1.
The prevalence of CVD symptoms in the population
examined is reported in Table 2, where cases have been
attributed to a given class based on the most severe degree
observed for either limb examined. Telangiectases are
common in young women, whereas varicose veins and
oedema are more prevalent in men and in patients older
than 50 years. Severe cases are more numerous in the
Table 1 Socio-demographic data of the population surveyed. M: male; F: female.
Year of survey
2003 2004 2005 Total
N % N % N % N %
Total 4869 100.0 16 251 100.0 10 539 100.0 31 659 100.0
Sex M 678 13.9 2425 14.9 1647 15.6 4750 15.0
F 4191 86.1 13 826 85.1 8892 84.4 26 909 85.0
Total 4869 100.0 16 251 100.0 10 539 100.0 31 659 100.0
Age [years] <30 1139 23.4 3859 23.7 2742 26.0 7740 24.4
30e49 828 17.0 3042 18.7 1850 17.6 5720 18.1
50 2902 59.6 9350 57.5 5947 56.4 18 199 57.5
Total 4869 100.0 16 251 100.0 10 539 100.0 31 659 100.0
Region Northern Italy 2587 54.2 7730 47.6 6185 58.7 16 502 52.3
Centre 1514 31.7 5031 31.0 3090 29.3 9635 30.5
Southern Italy
and Islands
672 14.1 3490 21.5 1264 12.0 5426 17.2
Total 4773 100.0 16 251 100.0 10 539 100.0 31 563 100.0
Family history Yes 2982 61.2 9915 61.0 6094 57.8 18 991 60.0
No 1336 27.4 4957 30.5 3824 36.3 10 117 32.0
Total 4318 88.7 14 872 91.5 9918 94.1 29 108 91.9
Missing 551 11.3 1379 8.5 621 5.9 2551 8.1
Therapeutic Options in CVD 513southern part of Italy and on the Islands (Sardinia and
Sicily). Family history is an important risk factor as well.
Table 3 displays the frequency of therapies used to treat
CVD by the responders as well as the advice for therapies
they received by the consulting physicians after the visits.
Multiple answers were possible in both cases, because the
subject could have been using more than one type of
therapy and the physicians may have suggested the use of
several treatments. We refrained from carrying out any
kind of confirmatory tests on the tabulations, because theTable 2 Severity of the CVI symptoms in the population studied
CEAP classification see text.
CEAP classification (%
C0 C1
Population Total 21.3 30.9
Sex M 35.7 11.5
F 18.7 34.3
Age [years] <30 31.6 38.2
30e49 19.5 35.9
50 17.5 26.2
Region Northern Italy 21.2 31.6
Centre 24.7 30.8
Southern Italy
and islands
15.4 28.8
Family history Yes 18.5 31.3
Missing 24.7 29.2
Year of survey 2003 19.5 33.6
2004 20.9 29.8
2005 22.8 31.3chi-square (c2) test, which would be the most adequate for
this kind of data, is very sensitive to large numbers and
would produce, correspondingly, meaningless significances.
Self-medication habits of Italian respondents
Drug therapy (in particular, bioflavonoids containing natural
remedies, mentioned by more than 80% of the respondents;
data not shown) or the use of compression stockings are the
most common options among the population studied(CEAP classification). M: male; F: female. Abbreviations for
of the total population)
C2 C3 C4 C6
28.6 10.0 8.7 0.5
32.8 8.1 10.9 1.0
27.9 10.3 8.4 0.4
19.2 7.7 3.2 0.1
28.7 9.9 5.8 0.2
32.7 11.0 12.0 0.7
28.7 9.4 8.6 0.5
28.3 8.3 7.6 0.4
29.0 15.1 11.2 0.5
30.6 10.3 8.8 0.5
27.7 9.7 8.3 0.5
27.0 9.7 10.2 0.0
30.3 10.0 8.6 0.4
26.8 10.1 8.3 0.8
Table 3 Therapies carried out by the respondents prior to the visit and recommended by the phlebologist after the diagnosis
(% of the total study population). Multiple answers were possible. M: male; F: female. Abbreviations for CEAP classification see
text. Data for compression stockings were collected in 2005 only. Total number of respondents examined: drug therapy: 31’434
(both performed and recommended); sclerotherapy: 31’371; compression stockings: 10’493 (only in 2005); surgical therapy:
31’378. NR: not recorded.
Drug therapy Compression stockings Sclerotherapy Surgical therapy
Carried out Recommended Carried
out
Recommended Carried
out
Recommended Carried
out
Recommended
Total population 19.60 70.80 11.10 55.60 6.30 19.20 7.10 17.90
Sex M 10.10 59.20 7.00 48.20 1.10 4.00 6.60 21.10
F 21.30 72.90 11.90 56.90 7.20 21.90 7.20 17.30
Family history 22.10 72.70 13.40 59.00 7.80 22.20 8.70 20.40
Age [years] <30 15.20 65.70 4.80 41.20 2.20 20.10 0.80 4.90
30e39 17.80 70.20 9.70 54.20 5.50 23.60 3.10 11.10
40e49 21.50 72.50 11.80 60.10 8.10 26.00 6.20 17.00
50e59 20.20 71.80 12.00 57.20 8.30 21.60 8.60 21.60
60e69 20.80 71.10 13.40 57.40 6.70 14.50 10.80 24.40
>70 19.30 70.00 11.50 56.00 3.40 6.70 9.00 18.80
Region Northern Italy 18.50 68.60 10.90 58.60 6.30 18.30 7.90 18.90
Centre 17.90 71.50 7.90 53.70 6.00 15.90 6.10 14.90
Southern Italy,
Islands
26.50 75.80 20.10 45.60 7.10 28.60 6.80 20.00
CEAP class C0 10.40 47.50 3.70 31.30 1.70 2.10 2.10 2.40
C1 17.80 74.20 7.50 49.30 6.90 29.90 2.50 2.10
C2 22.60 78.20 15.30 71.80 8.10 22.00 11.80 37.10
C3 25.70 81.90 18.30 70.80 6.30 14.90 9.80 24.30
C4 31.00 78.60 21.00 72.90 9.70 19.40 17.20 39.90
C6 37.70 76.00 26.50 79.50 11.00 11.60 18.50 40.40
Year of survey 2003 25.30 68.20 NR NR 6.20 17.50 7.40 18.70
2004 17.40 70.80 NR NR 6.70 21.80 7.70 18.90
2005 20.50 72.10 11.10 55.60 5.80 16.00 6.20 15.90
514 E.M. Marone et al.(>30%), regardless of age and sex of the respondents.
Young people show a tendency to prefer drug treatment to
compression stockings. Drug therapy is widespread and well
accepted in Southern Italy and the Islands, whereas
compression stockings are more popular in Central Italy.
Table 4 reports the multivariate OR for the types of
therapy carried out among the respondents. Women are
more likely than men to be employing any kind of therapy
before enrolling for the survey (OR of 2.37 for medical
treatment, 1.29 for surgical treatment and 5.72 for scle-
rotherapy). Surgical therapy is recommended to women at
a lower frequency than to men (OR: 0.85). This may be due,
on the one hand, to the larger frequency of severe forms in
the participating men (Table 2), but some of the female
respondents may have already had some kind of surgical
therapy as suggested by the higher probability among
women to have undergone surgery in the past (OR: 1.29).
People older than 50 years are more likely to have already
had drug therapy (OR: 1.19), or surgery for CVD (OR: 3.31)
as compared with younger subjects. Respondents in
Southern Italy use drugs (OR: 1.49) or compression stockings
(OR: 1.91) to treat their CVD more often than in the
northern regions. Surgical therapy, on the other hand, is
more frequently practised in Northern Italy (OR for Central
Italy: 0.79; for Southern Italy and Islands: 0.77). Knowledgeby the respondents of the occurrence of CVD in the family
seem to influence their treatment habits, because people
with a family history of CVD treat their symptoms more
often than those who did not report any history of CVD in
their families (OR ranging from 1.35 for drug therapy to
1.99 for surgical therapy). As expected, the use of any kind
of therapy in CVD increases with increasing severity of the
diseases: people with CEAP C2 are 4 times more likely to
treat their CVD, and approximately 8 times for stages C5eC6
as compared with the reference class C0.
Treatment recommendations by Italian
phlebologists
Regardless of the geographic region they are located in,
Italian physicians tend to recommend CVD treatment in
earlier CVD stages (Table 3). Thus, they seem to trust the
therapy to prevent progression of the disease. In general,
approximately 82% of the participants have been recom-
mended a therapy, as opposed to 29% who already carried
out one (data not shown). Most physicians tend to propose
first the use of conservative methods such as drug therapy
or compression stocking for mild CVD, opting for surgical
interventions (which in our case included also endovenous
laser or radiofrequency ablation and foam sclerotherapy of
Table 4 Therapies carried out and recommended e multivariate OR (95% confidence intervals).
Categorical variables Multivariate odds ratio
Drug therapy Compression stockings* Sclerotherapy Surgical therapy
Carried out Recommended Carried out Recommended Carried out Recommended Carried out Recommended
Sex (reference class: male)
Female 2.37*
(2.13e2.64)
1.61*
(1.49e1.73)
1.77*
(1.43e2.20)
1.38*
(1.22e1.56)
5.72*
(4.33e7.55)
4.96*
(4.22e5.84)
1.29*
(1.13e1.48)
0.85*
(0.78e0.93)
Age [years]
(reference class: <30)
30e49 1.21*
(1.11e1.33)
1.03
(0.95e1.12)
1.32*
(1.07e1.62)
1.31*
(1.15e1.49)
1.74*
(1.50e2.02)
1.06
(0.97e1.15)
2.23*
(1.84e2.69)
1.53*
(1.36e1.72)
50 1.19*
(1.11e1.29)
0.96
(0.90e1.03)
1.35*
(1.14e1.61)
0.99
(0.89e1.10)
1.61*
(1.41e1.83)
0.65*
(0.60e0.70)
3.31*
(2.81e3.90)
1.72*
(1.56e1.90)
Region (reference class: Northern Italy)
Central Italy 1.04
(0.97e1.12)
1.26*
(1.19e1.34)
0.77*
(0.66e0.90)
0.89*
(0.80e0.98)
1.04(0.93e1.16) 0.90*
(084e0.97)
0.79*
(0.79e0.88)
0.76*
(0.70e0.82)
Southern Italy
and islands
1.49*
(1.38e1.61)
1.31*
(1.22e1.42)
1.91*
(1.60e2.27)
0.48*
(0.42e0.55)
1.10(0.97e1.25) 1.72*
(1.59e1.86)
0.77*
(0.68e0.88)
0.90*
(0.83e0.99)
Family history (reference class: lack of family history)
One or both parents 1.35*
(1.27e1.45)
1.07*
(1.01e1.13)
1.60*
(1.39e1.85)
1.21*
(1.11e1.33)
1.78*(1.58e1.99) 1.26*
(1.18e1.35)
1.99*
(1.79e2.22)
1.65*
(1.53e1.78)
CEAP classification (reference class: C0)
C1 1.55*
(1.41e1.72)
2.85*
(2.66e3.06)
1.71*
(1.32e2.22)
2.00*
(1.78e2.25)
3.17*
(2.58e3.90)
17.16*
(14.35e20.52)
0.99
(0.79e1.23)
0.85
(0.68e1.05)
C2 2.19*
1.98e2.42)
3.82*
(3.82e3.54)
3.92*
(3.07e5.02)
5.62*
(4.75e6.66)
3.90*
(3.17e4.79)
13.37*
11.14e16.03)
4.71*
(3.90e5.69)
21.21*
(17.87e25.17)
C3 2.52*
(2.24e2.84)
4.93*
(4.32e5.39)
4.24*
(3.22e5.59)
5.68*
(4.99e6.45)
3.00*
(2.35e3.81)
7.17*
(5.86e8.78)
4.01*
(3.24e4.98)
11.71*
(9.71e14.11)
C4 3.43*
(3.04e3.47)
3.96*
(3.55e4.42)
5.75*
(4.34e7.62)
5.76*
(4.69e6.91)
4.92*
(3.90e6.21)
12.11*
(9.89e14.82)
7.14*
(5.82e8.77)
23.43*
(19.47e28.18)
C5eC6 5.51*
(3.83e7.94)
3.42*
(2.30e5.08)
8.42*
(4.80e14.78)
10.30*
(5.76e18.44)
6.35*
(3.55e11.36)
7.81*
(4.45e13.70)
7.46*
(4.44e11.99)
24.64*
(16.78e36.18)
*Significant factor, p< 0.01.
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Table 5 Correlation between recommendation by the phlebologist of a therapeutic approach to CVI and reporting of having
carried out a therapy by the respondents.
Carried out Recommended
Drug
therapy
Compression
stockings*
Sclerotherapy Surgery
Drug therapy Yes 86.8% 68.5% 24.6% 25.3%
No 66.8% 52.3% 17.9% 16.0%
Compression stockings Yes 85.9% 54.2% 23.8% 32.1%
No 70.3% 88.1% 15.1% 13.9%
Sclerotherapy Yes 82.2% 78.2% 45.2% 29.2%
No 69.9% 54.2% 17.5% 17.0%
Surgery Yes 77.8% 78.9% 21.7% 49.0%
No 70.2% 54.0% 19.0% 15.4%
*Data on compression stockings were collected only in 2005.
516 E.M. Marone et al.saphenous veins) only in CEAP stages C3eC6. OR for the
recommendations reflects those observed for the use of the
therapies by the respondents. Table 5 reveals an interesting
pattern in the data: physicians tend to suggest a treatment
to more people than are already carrying out one, and they
also tend to recommend roughly the same therapy as the
one already used by the respondents. For instance, drug
therapy is recommended to approximately 86.8% of the
subjects who were already receiving one and to 67% of
those who were currently or previously had not received
drug treatment.Discussion
This studyhas shown thatCVD is awidespreaddisease in Italy,
with frequencies comparablewith those reported fromother
countries.8,9 Of all 31 669 participants, only approximately
20%areunaffectedbyCVD (Table 1;C0: 21.3%),with a slightly
higher prevalence of the disease in Southern Italy and on the
Islands. More than 50% of the volunteers were assigned to
CEAP C0 and C1. Thus, results from colour duplex ultraso-
nography revealed a distinct pattern from that provided by
subjective symptoms, as discussed already elsewhere.6 The
study attracted people who would like to have a thorough
physical examination of their legs with regard to blood
circulation. We are aware that this may have produced some
bias in the recruitment; nevertheless, our results are in
agreement with those of the former reports.8e12
The physicians are aware of the importance of pre-
venting or halting the progression of CVD, as shown by
the advice to start a therapy given to a large percentage
of the population examined. A cure of CVD is not yet
available and prevention studies have not been carried
out and nor is prevention expected from any kind of
care; yet the Italian specialists recommend noninvasive
treatments such as drug therapy (mostly herbal remedies;
data not shown) and use of compression stockings to
a large number of patients they have seen. This recom-
mendation is in good agreement with the widespread use
of herbal remedies (80% of which are bioflavonoids) by
the respondents. This suggests that they may expect
some kind of prophylactic effect from both treatments. Itis somewhat surprising that recommendation of the use
of compression stockings, until recently believed to be
the treatment of choice in CVD, is now being gradually
replaced by that of drug therapy. In central Italy, in the
South and on the Islands, in particular, drug remedies
(both synthetic or natural) are recommended preferen-
tially over compression therapy.
Sclerotherapy is still widely recommended in the
Southern part of Italy and on the Islands for stages C1eC2,
most likely to remove aesthetically unsatisfactory telangi-
ectases and small varicose veins in young people (OR for
people older than 50 years: 0.65).
The population who enrolled in this programme seems to
be aware of the problems CVD entails. Women are more
informed of CVD problems than men, as indicated by the
number of women volunteering for the survey. The
aesthetic problems linked to CVD are most likely an
important factor to them. Young people are also conscious
of the problem, as testified by the large number of young
subjects (about 25% of the total respondents) enrolling in
the prevention programme.
This study has several limitations. On the one hand, the
choice of a non-random sample, a consequence of the
design of the programme, could lead to the conclusion that
the results may not be representative of the whole Italian
population; yet the results obtained largely conform to
those published in the earlier reports8e12 and this rein-
forces the meaningfulness of this survey. The design of the
survey has been optimised, although slightly, at each new
instance by adding or modifying the case report form used.
This has made the definition of the analysable sample
different for each year and the total number of cases for
each analysis varied, thus reducing the power of the
conclusions that can be drawn. A more relevant limitation,
intrinsic to the design chosen, has certainly been the lack
of follow-up of the patients to assess adherence to the
therapeutic scheme recommended. Nevertheless, we feel
that the programme has contributed to raising the aware-
ness of the Italian population to CVD, as indicated by the
increasing number of respondents (from 4869 in 2003 to
10 539 in 2005). Epidemiologically, it also provides a useful
insight into the prescribing patterns of Italian specialists in
the treatment of CVD and shows that the population
Therapeutic Options in CVD 517interviewed is able to practise responsible self-medication
for their CVD problems.
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